Fundraising FoxBeeken BioMedical
Stoughton, US · Delaware LLC
Find your way into Beeken BioMedical
Sign up to see every warm intro you have to Beeken BioMedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Beeken BioMedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NuStat markets an over-the-counter bleeding-control product that the page states meets or exceeds U.S. Department of Defense specifications for quality and functionality. The product is positioned in the medical/hemostatic wound-care category.
Founders & leadership
KR
Kendall RichardPresident & CEOKendall Richard has held positions in medical device sales, marketing, and general management. He is President and CEO of Beeken BioMedical, which develops hemostatic dressings and liquid bandage products for wound care applications.
PB
Peter BeemsterboerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.8M disclosed across 2 of 3 rounds · 2014–2020
▶$6.3MraisedAug 2020 · 69 investors · BiotechnologyRule 506(b)
▶$6.3MraisedAug 2020 · 69 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter BeemsterboerExecutive Officer, Director, Promoter
- Charles BlixtDirector
- Richard KendallExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- Minimum investment
- $14.2K
- First sale
- May 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedAug 2020 · 19 investors · BiotechnologyRule 506(b)
▶$2.5MraisedAug 2020 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter BeemsterboerExecutive Officer, Director, Promoter
- Kendall RichardExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $18K
- First sale
- Oct 2014
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Beeken BioMedical.
Frequently asked questions
- What does Beeken BioMedical do?
- NuStat markets an over-the-counter bleeding-control product that the page states meets or exceeds U.S. Department of Defense specifications for quality and functionality. The product is positioned in the medical/hemostatic wound-care category.
- How much funding has Beeken BioMedical raised?
- Beeken BioMedical has disclosed $8.8M raised across 2 of its 3 known rounds.
- Where is Beeken BioMedical headquartered?
- Beeken BioMedical is headquartered in Stoughton, US.